Non-alcoholic fatty liver disease: Hepatokines mediate its impact on metabolic diseases and help to identify subtypes
Non-alcoholic fatty liver disease (NAFLD) is an important risk factor for type 2 diabetes and cardiovascular diseases. In a Perspective in Cell Metabolism, Norbert Stefan from the University of Tübingen, Helmholtz Munich ...
Feb 7, 2023
0
12